治疗前18F-FDG PET/CT体积参数对结直肠癌肝转移患者的预后意义:系统综述与荟萃分析
该系统综述与荟萃分析评估了治疗前18F-FDG PET/CT体积参数(MTV和TLG)对结直肠癌肝转移患者肝转移灶的预后价值。共纳入10项研究494例患者,结果显示较高的MTV和TLG与无事件生存期和总生存期显著较差相关。
要点
- 治疗前肝转移灶MTV和TLG较高与无事件生存期较差显著相关。
- 治疗前肝转移灶MTV和TLG较高与总生存期较差显著相关。
- 18F-FDG PET/CT的MTV和TLG可作为结直肠癌肝转移患者的预后预测指标。
核心结论
- 治疗前肝转移灶较高的MTV和TLG被确定为结直肠癌肝转移患者更差的预后参数。
- 18F-FDG PET/CT的MTV和TLG可用作预后预测指标。
研究设计与样本
- 系统综述与荟萃分析,系统检索668条记录,最终纳入10项研究共494例患者。
- 纳入标准为治疗前使用18F-FDG PET/CT作为影像工具、包含肝转移灶体积参数(MTV和TLG)并报告生存数据的研究。
主要发现
- MTV对无事件生存期的合并HR为1.55(95%CI,1.21-1.99;P=0.0006),有统计学意义。
- TLG对无事件生存期的合并HR为1.64(95%CI,1.23-2.19;P=0.0009),有统计学意义。
- MTV对总生存期的合并HR为1.72(95%CI,1.32-2.23;P<0.0001),有统计学意义。
- TLG对总生存期的合并HR为2.09(95%CI,1.48-2.96;P<0.0001),有统计学意义。
关键数值与推荐
- 无事件生存期和总生存期作为生存标志物,通过风险比(HR)及95%置信区间(CI)的效应量确定对生存的影响。
临床怎么用
- 对结直肠癌肝转移患者,治疗前可考虑测量肝转移灶的MTV和TLG以辅助预后评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Colorectal liver metastasis (CRLM) remains a clinical challenge due to the lack of reliable prognostic parameters. We performed a systematic review and meta-analysis of the prognostic value of pretreatment 18F-FDG PET/CT volumetric parameters for hepatic metastatic lesions (HMLs) in patients with CRLM. METHODS: A systematic search was performed using the following combination of keywords: CRLM, FDG, PET, and prognosis. The inclusion criteria were studies using 18F-FDG PET/CT as an imaging tool before treatment, including volumetric parameters (metabolic tumor volume [MTV] and total lesion glycolysis [TLG]) for HMLs, and reported survival data. Event-free survival and overall survival were considered as survival markers. The effect on survival was determined by the effect size of the hazard ratio (HR) with 95% confidence interval (CI). RESULTS: Our systematic search identified 668 records, and a total of 10 studies comprising 494 patients were included. The pooled HRs of the prognostic value of the MTV and TLG for event-free survival were 1.55 (95% CI, 1.21-1.99; P = 0.0006) and 1.64 (95% CI, 1.23-2.19; P = 0.0009) with significance, respectively. The pooled HRs of the prognostic value of the MTV and TLG for overall survival were 1.72 (95% CI, 1.32-2.23; P < 0.0001) and 2.09 (95% CI, 1.48-2.96; P < 0.0001) with significance, respectively. CONCLUSIONS: Higher MTV and TLG for HMLs before treatment were identified as worse prognostic parameters in patients with CRLM. The MTV and TLG of 18F-FDG PET/CT could be used as predictors of prognosis.
引用
- Kim YI, Lee HS, Choi JY, et al. Prognostic Significance of Pretreatment 18F-FDG PET/CT Volumetric Parameters in Patients With Colorectal Liver Metastasis: A Systematic Review and Meta-analysis. Clin Nucl Med. 2021. PMID: 33443946. doi:10.1097/RLU.0000000000003479
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。